We report the functional expression of the mammalian muscle-adipocyte insulin-sensitive hexose transporter in Xenopus laevis oocytes. Oocytes microinjected with RNA synthesized in vitro showed enhanced hexose transport activity compared with uninjected controls. However, like the endogenous oocyte hexose transporter, activity was stimulated only twofold by 1 ,uM insulin. X. laevis oocytes injected with in vitro-synthesized RNA encoding the human insulin proreceptor expressed a functionally active insulin receptor that enhanced the insulin sensitivity of injected oocytes. This increase was not observed in oocytes expressing a mutant insulin receptor that lacked protein tyrosine kinase activity. In the presence of the coexpressed human insulin receptor, insulin induced a two-to threefold increase in hexose transport. The muscle-, brain-, and liver-type hexose carriers normally expressed in tissues with different responses to insulin exhibited the same insulin sensitivity when expressed in oocytes. This was observed whether or not the insulin signal was transduced through a coexpressed human insulin receptor or the endogenous oocyte insulin-like growth factor I receptor. We conclude that the expressed human insulin receptor is able to couple efficiently with preexisting postreceptor regulatory pathways in oocytes and that the regulation of hexose transport in these cells can be mediated through the combined actions of the expressed human insulin receptor and the endogenous oocyte insulin-like growth factor I receptor.Transport of glucose in most mammalian cell types occurs by carrier-mediated facilitated diffusion down a concentration gradient (41,48). Recent studies indicate that this facilitated hexose uptake is mediated by a family of structurally related integral membrane proteins. Thus, a number of putative hexose transport proteins that have marked differences in their patterns of tissue-specific expression have been cloned. These include a cDNA clone encoding a protein expressed largely, but not exclusively, in HepG2 hepatoma cells and the brain (3,29); one expressed in the liver, the pancreatic islets, and the kidneys (13, 44); one expressed in fetal skeletal muscle (24); and another expressed almost exclusively in fat cells and in adult skeletal and cardiac muscles (2,5,12,18,21). Functional studies indicate that at least three of these proteins (HepG2 brain, liver, and adult skeletal muscle) are, indeed, hexose carriers (2,37,44,45).Comparison of the deduced amino acid sequences of the cloned transporters indicates homology in primary structure (2,3,5,12,13,18,21,24,29,44). In addition, the hydropathy plots of the different transporters are virtually superimposable and compatible with the proposed model for the orientation of the HepG2 glucose transporter in the cell membrane (29, 44). Sequence similarity is higher in the putative hydrophobic membrane-spanning segments than in the extramembranous more hydrophilic domains. Thus, each transporter differs in the length and/or the amino acid sequence of the a...